4//SEC Filing
Nantahala Capital Management, LLC 4
Accession 0001104659-25-007682
CIK 0001403708other
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 6:39 PM ET
Size
8.6 KB
Accession
0001104659-25-007682
Insider Transaction Report
Form 4
Evoke Pharma IncEVOK
Harkey Wilmot B.
10% Owner
Transactions
- Sale
Common Stock
2025-01-28$4.39/sh−41$180→ 148,153 total(indirect: See footnote)
Nantahala Capital Management, LLC
10% Owner
Transactions
- Sale
Common Stock
2025-01-28$4.39/sh−41$180→ 148,153 total(indirect: See footnote)
Mack Daniel
10% Owner
Transactions
- Sale
Common Stock
2025-01-28$4.39/sh−41$180→ 148,153 total(indirect: See footnote)
Footnotes (1)
- [F1]Nantahala Capital Management, LLC ("NCM"), an investment adviser to certain private funds and managed accounts (the "NCM Investors") that hold the Evoke Pharma, Inc. ("Issuer") securities disclosed in this statement, may be deemed a beneficial owner of such securities. Each of Mr. Wilmot B. Harkey and Mr. Daniel Mack may be deemed a beneficial owner of Issuer securities beneficially owned by NCM. Each of NCM, Mr. Harkey and Mr. Mack disclaims beneficial ownership of the Issuer's securities disclosed herein except to the extent of their respective pecuniary interests therein.
Documents
Issuer
Evoke Pharma Inc
CIK 0001403708
Entity typeother
IncorporatedMA
Related Parties
1- filerCIK 0001472322
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 6:39 PM ET
- Size
- 8.6 KB